Preparation method of cholesterol-consuming nano-reactor and application thereof
The "one-pot method" to prepare ZIF@COD/IR820 nanoparticles and the membrane protein extraction method to prepare HM/ZIF@COD/IR820 nanoreactor solved the problems of complex synthesis and insufficient targeting of existing liver cancer treatment drugs, achieved significant tumor cell targeting and cholesterol consumption effects, and improved the treatment effect of liver cancer.
Patent Information
- Application Number
- CN202411474957.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-22
- Publication Date
- 2025-10-10
- Estimated Expiration
- 2044-10-22
AI Technical Summary
Among existing liver cancer treatment drugs, the synthesis steps of 2-methylimidazole zinc metal frame nanoreactor are complex, the cholesterol oxidase loading efficiency is low, and it lacks targeting, resulting in insignificant cholesterol consumption effect, affecting the treatment effect.
ZI F@COD/I R820 nanoparticles were prepared by a one-pot method. Hepatocellular carcinoma and erythrocyte membrane fragments were obtained by membrane protein extraction. The fragments were combined in a liposome extruder and loaded with COD/I R820 nanoparticles using hybrid cell membrane camouflage. Cholesterol oxidase solution was prepared in one pot, centrifuged, and the precipitate was washed to obtain a cholesterol-consuming nanoreactor named HM/ZI F@COD/I R820.
The prepared nanoreactor has excellent cholesterol-consuming nanoparticles with excellent targeting, which can increase the cholesterol consumption of tumor cells, promote tumor cell apoptosis, and improve the treatment effect of liver cancer.